Daewon Pharmaceutical Co., Ltd.

Informe acción KOSE:A003220

Capitalización de mercado: ₩312.2b

Daewon Pharmaceutical Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Seung-Ryel Baek

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO16.3yrs
Participación del CEO16.0%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva16.3yrs

Actualizaciones recientes de la dirección

Recent updates

There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings

Mar 21
There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings

Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Mar 26
Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?

Mar 07
Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?

Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?

Feb 18
Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?

Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 31
Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?

Jan 13
Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?

Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Dec 24
Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly

Dec 10
Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly

Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?

Nov 22
Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?

CEO

Seung-Ryel Baek (65 yo)

16.3yrs

Permanencia

Mr. Seung-Ryel Baek serves as the Chief Executive Officer of Daewon Pharmaceutical Co. Ltd., and has also been its Director since March 14, 2008. Mr. Baek serves as President of Daewon Pharmaceutical Co. L...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Seung-Ryel Baek
Vice Chairman16.3yrssin datos16.05%
₩ 50.1b
Seungho Baek
Chairman16.3yrssin datos15.83%
₩ 49.4b
Jeong-Hui Kim
Director15.3yrssin datossin datos

16.3yrs

Permanencia media

Junta con experiencia: Los miembros de la junta directiva de A003220 son experimentados ( 16.1 años antigüedad media).